The PCOS-to-PMOS shift in the broader history of nomenclature changes and its uncertain impact on clinical practice
Related Experiment Video
Updated: Oct 30, 2026

A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice
Published on: July 5, 2024
Elina Aleksejeva-Zagura1,2, Piotr Laudański3,4,5, Ganesh Acharya6,7
1Institute of Genomics, University of Tartu, Tartu, Estonia.
Abstract:
Proposed renaming of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) aims to broaden multidisciplinary care. However, it may obscure reproductive manifestations and introduce phenotypic ascertainment bias. Historical examples of nomenclature changes suggest that clinical benefits depend heavily on diagnostic, therapeutic, and etiological advances and education. Although formal cost-effectiveness analysis of nomenclature changes are lacking, our preliminary estimates suggest that implementation may entail substantial cost and healthcare resource requirements, while its clinical benefits remain uncertain.
Related Concept Videos
Methods of Documentation II: POMR
¹H NMR: Pople Notation
A proton...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Oogenesis
